COWZ vs IBB
Pacer US Cash Cows 100 ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.49% for COWZ.
- • COWZ pays a higher dividend yield (1.99%).
Side-by-side metrics
| Metric | COWZ | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.99% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $17.59B | $9.09B |
YTD return | 6.25% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.65 | 0.69 |
P/E ratio | 16.32 | 24.89 |
Last price | $63.92 | $197.34 |
Inception | — | — |
Issuer | Pacer | iShares |
COWZ top holdings
| BKNG | Booking Holdings Inc | 2.21% |
| HCA | HCA Healthcare Inc | 2.15% |
| LOW | Lowe's Companies Inc | 2.15% |
| CMCSA | Comcast Corp Class A | 2.12% |
| UBER | Uber Technologies Inc | 2.10% |
| BMY | Bristol-Myers Squibb Co | 2.07% |
| MO | Altria Group Inc | 2.05% |
| GD | General Dynamics Corp | 2.04% |
| GILD | Gilead Sciences Inc | 2.01% |
| TMUS | T-Mobile US Inc | 1.93% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About COWZ
COWZ (Pacer US Cash Cows 100 ETF) is 100 Russell 1000 stocks with highest free cash flow yield. Managed by Pacer, the fund carries $17.6B in assets under management, an expense ratio of 0.49%, a dividend yield of 1.99%. Its largest holding is Booking Holdings Inc (BKNG), which represents 2.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 14.3%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.